NCT06533592

Brief Summary

The main objective of the trial is to compare the effect of two end-to-end duct-to-duct anastomosis surgical techniques using the continuous suture method versus interrupted method (control group) on reducing the risk of bile leakages in the 90-day follow-up period after liver transplantation and other postoperative complications resulting from them i.e.: the occurrence of a critical stenosis in the duct-to-duct anastomosis within 90 days. In addition, as part of the research experiment, long-term biliary complications will be assessed, i.e. occurring over a period of more than 90 days (a 2-year observation period of patients was assumed). As part of the trial 284 patients qualified for the procedure of liver transplantation from a deceased donor will be included, in whom end-to-end anastomosis of the bile ducts will be performed. After entering the study, patients will be randomized to one of the groups. In the group of 142 patients, duct-to-duct anastomosis will be performed using an interrupted suture (control group), and the remaining patients will be performed using the continuous suture technique. The analysis will also include surgical complications, complications related to early and late graft function, retransplantation and overall survival. Additionally the analyses an analysis of the impact of the occurrence of a biliary complication on the quality of life of patients after liver transplantation will be performed on the basis of the EORTC QLQ-C30 forms. The period of observation of the patient after the procedure is planned for 24 months.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
284

participants targeted

Target at P75+ for not_applicable

Timeline
28mo left

Started Sep 2024

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress41%
Sep 2024Sep 2028

First Submitted

Initial submission to the registry

July 9, 2024

Completed
23 days until next milestone

First Posted

Study publicly available on registry

August 1, 2024

Completed
2 months until next milestone

Study Start

First participant enrolled

September 28, 2024

Completed
2.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2026

Expected
1.8 years until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2028

Last Updated

October 24, 2024

Status Verified

June 1, 2024

Enrollment Period

2.1 years

First QC Date

July 9, 2024

Last Update Submit

October 21, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • Bile leakage

    Defined as bilirubin concentration in the drain fluid at least 3 times the serum bilirubin concentration or as the need for radiologic or operative intervention resulting from biliary collections or bile peritonitis up to 90 days post transplantation

    90 days post transplantation

Secondary Outcomes (6)

  • Critical biliary stricture

    90 days post transplantation

  • Other surgical complications

    90 days post transplantation

  • Long-term biliary complications

    2 years post transplantation

  • Overall survival

    2 years post transplantation

  • Overall graft survival

    2 years post transplantation

  • +1 more secondary outcomes

Study Arms (2)

Continuous suture technique

EXPERIMENTAL

Biliary duct-to-duct anastomosis performed with continous suture technique

Procedure: Continous suture technique

Interrupted suture

ACTIVE COMPARATOR

Biliary duct-to-duct anastomosis performed with interrupted suture technique - control group

Procedure: Interrupted suture technique

Interventions

Duct-to-duct anastomosis will be performed using continuous suture technique for study group

Continuous suture technique

Duct-to-duct anastomosis will be performed using an interrupted suture for control group,

Interrupted suture

Eligibility Criteria

Age18 Years - 75 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • age over 18
  • elective liver transplantation
  • informed consent to participate in the study
  • recipient bile duct diameter over 3mm
  • donor bile duct diameter over 3mm

You may not qualify if:

  • age below 18
  • pregnancy
  • living donor liver transplantation
  • split-liver or reduced-size liver transplantation
  • liver transplantation other than from brain death donor
  • liver transplantation with hepaticojejunostomy
  • patients undergoing re-transplantation
  • multi-organ transplantation
  • recipient bile duct diameter below 3mm
  • donor bile duct diameter below 3mm

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Department of General, Transplantation and Liver Surgery UCC MUW

Warsaw, Masovian Voivodeship, 02-097, Poland

RECRUITING

MeSH Terms

Conditions

Constriction, Pathologic

Condition Hierarchy (Ancestors)

Pathological Conditions, AnatomicalPathological Conditions, Signs and Symptoms

Central Study Contacts

Krzysztof Dudek, MD, PhD

CONTACT

Jan Stypułkowski, MD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 9, 2024

First Posted

August 1, 2024

Study Start

September 28, 2024

Primary Completion (Estimated)

November 1, 2026

Study Completion (Estimated)

September 1, 2028

Last Updated

October 24, 2024

Record last verified: 2024-06

Locations